您的位置: 首页 > 2018年9月 第49卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

糖尿病足患者创面病原菌分布及耐药性变迁

Change of pathogen distribution and drug resistance in patients with diabetic foot

来源期刊: 广州医药 | 81-85 发布时间:2021-11-29 收稿时间:2025/11/13 17:19:08 阅读量:28
作者:
关键词:
糖尿病足G+菌G-菌真菌耐药性
Diabetic FootG+ bacteriaG- bacteriaFungiDrug Resistance
DOI:
10.3969/j.issn.1000-8535.2018.05.020
收稿时间:
2018-06-06 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 了解广东地区糖尿病足患者创面病原菌分布及耐药性变迁。方法 回顾性分析A组(2010年1月—2014年12月就诊的糖尿病足患者)和B组(2015年1月—2018年1月就诊的糖尿病足患者)研究者创面病原菌分布及耐药性变迁。结果 B组中创面G+菌及G-菌均有下降趋势且G-菌下降较快,细菌种类明显增加,真菌及混合感染明显上升,A组以金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌感染为主;B组以金黄色葡萄球菌、奇异变形杆菌、铜绿假单胞菌及真菌感染为主;B组相对于A组的细菌耐药性增加。结论 近年来糖尿病足患者病原菌种类明显增加且混合感染及真菌感染上升,且其耐药性增加,因此早期经验用药而后根据药敏选择抗菌药物治疗是糖尿病足感染治疗的关键。
Objective To investigate the distribution and drug resistance of pathogenic bacteria in diabetic foot wounds in Guangdong area. Methods Patients with diagnosis of diabetic foot between group A (from Jan 2010~Dec 2014 ) and group B (from Jan 2015 to Jan 2018) were retrospectively analyzed. We studied the bacteria distribution and drug resistance of pathogenic changes of group A and group B. Results In group B, both G+ and G- bacteria had a decreased trend while G- bacteria decreased rapidly, but the species of bacteria increased obviously just as fungi and mixed infection increased obviously. Bacteria infection in group A were mainly about Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli wihle group B were Staphylococcus aureus, Proteus mirabilis, Aeruginosa and Fungal infection; the resistance of group B to A was lower. Conclusion In recent years, kinds of pathogenic bacteria of diabetic foot were significantly increased and the mixed infection and increased fungal infection as well as its drug resistance increased, so the early experience of medication choice of antibiotics based on drug sensitivity and treatment are the key to the treatment of diabetic foot infection.
1、 IMRAN S, ALI R, MAHBOOB G. Frequency of lower extremity amputation in diabetics with refer extremity amputation in diabetics with refer encetoglycemic control and Wagner's grades[J]. JCPSP-J Coll Physici,2006, 16(2): 124-127. IMRAN S, ALI R, MAHBOOB G. Frequency of lower extremity amputation in diabetics with refer extremity amputation in diabetics with refer encetoglycemic control and Wagner's grades[J]. JCPSP-J Coll Physici,2006, 16(2): 124-127.
2、 萧正华,陈定宇,刁学廉,等. 血浆免疫指标变化与糖尿病足部感染[J]. 广州医学院学报,2002,30(1):35-37. 萧正华,陈定宇,刁学廉,等. 血浆免疫指标变化与糖尿病足部感染[J]. 广州医学院学报,2002,30(1):35-37.
3、 SINGH N,ARMSTRONG D G,LIPSKY B A. Preventing foot ulcers in patients with diabetes[J]. JAMA,2005,293(2): 217-220. SINGH N,ARMSTRONG D G,LIPSKY B A. Preventing foot ulcers in patients with diabetes[J]. JAMA,2005,293(2): 217-220.
4、 GEMECHU F W,SEEMANT F,CURLEY C A. Diabetic foot infections[J]. Am Fam Physician,2013,88(3): 177-181. GEMECHU F W,SEEMANT F,CURLEY C A. Diabetic foot infections[J]. Am Fam Physician,2013,88(3): 177-181.
5、 COCKERILL F R. Performance standards for antimicrobial susceptibility testing, twenty-first informational supplement[M].USA: Clinical and Laboratory Standards Institute,2015. COCKERILL F R. Performance standards for antimicrobial susceptibility testing, twenty-first informational supplement[M].USA: Clinical and Laboratory Standards Institute,2015.
6、 柳迎昭,王丽,陈建国. 糖尿病足感染患者病原菌分布及耐药性分析[J]. 山西医药杂志,2014,43(19):2264-2266. 柳迎昭,王丽,陈建国. 糖尿病足感染患者病原菌分布及耐药性分析[J]. 山西医药杂志,2014,43(19):2264-2266.
7、 邓晓龙,肖立虎,陈大伟,等. 糖尿病足溃疡伴感染无菌棉拭子擦拭取样及深部组织活检取样细菌培养的一致性研究[J]. 中国糖尿病杂志,2014,4(7):504-508. 邓晓龙,肖立虎,陈大伟,等. 糖尿病足溃疡伴感染无菌棉拭子擦拭取样及深部组织活检取样细菌培养的一致性研究[J]. 中国糖尿病杂志,2014,4(7):504-508.
8、 李慧琴,苏晓飞,丁波,等. 218 例糖尿病足患者临床特征及高危因素分析[J]. 中华内分泌代谢杂志,2012,28(6):492-495. 李慧琴,苏晓飞,丁波,等. 218 例糖尿病足患者临床特征及高危因素分析[J]. 中华内分泌代谢杂志,2012,28(6):492-495.
9、 沈秋燕,林迪妮,朱虹,等.糖尿病足合并感染患者754株病原菌分布及耐药性分析[J]. 中华医学杂志,2014,94(12):889-894. 沈秋燕,林迪妮,朱虹,等.糖尿病足合并感染患者754株病原菌分布及耐药性分析[J]. 中华医学杂志,2014,94(12):889-894.
10、 何杏仪,黄景胜,张莉. 糖尿病足合并感染患者病原菌分布及耐药性变迁[J]. 今日药学,2017,11(27):767-770. 何杏仪,黄景胜,张莉. 糖尿病足合并感染患者病原菌分布及耐药性变迁[J]. 今日药学,2017,11(27):767-770.
11、 王彬. 38 例糖尿病足感染患者病原菌特点及药敏回顾分析[J]. 糖尿病新世界,2015,(3):7-8. 王彬. 38 例糖尿病足感染患者病原菌特点及药敏回顾分析[J]. 糖尿病新世界,2015,(3):7-8.
12、 RAMAKANT P, VERMA A K, MISRA R, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? [J]. Diabetologia,2011,54(1): 58-64. RAMAKANT P, VERMA A K, MISRA R, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? [J]. Diabetologia,2011,54(1): 58-64.
13、 谢光云,吴世木,刘爽,等. 糖尿病足患者伤口感染的病原菌分布及药敏结果分析[J]. 中华医院感染学杂志,2017,17(27):3897-3990. 谢光云,吴世木,刘爽,等. 糖尿病足患者伤口感染的病原菌分布及药敏结果分析[J]. 中华医院感染学杂志,2017,17(27):3897-3990.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录